NEW YORK--(BUSINESS WIRE)-- Fera Pharmaceuticals announced the launch today of Garamycin (gentamicin sulfate) Ophthalmic Solution USP.
Garamycin Ophthalmic Solution, a broad spectrum anti-infective, is indicated for the treatment of ocular bacterial infections such as conjunctivitis, keratitis and blepharitis.
Garamycin is a trusted brand name and the product is a favorite among physicians who are looking for a single ingredient anti-infective ophthalmic solution.
About Fera Pharmaceuticals, LLC
Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. For more information visit www.ferapharma.com.
Garamycin is a registered trademark of Fera Pharmaceuticals.
Fera Pharmaceuticals, LLC
Susan McDougal, 516-277-1450
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Hospitals Infectious Diseases Optical Pharmaceutical General Health